Mesenchymal stem cells enhanced cardiac nerve sprouting via nerve growth factor in a rat model of myocardial infarction

Current Pharmaceutical Design

Volumn 20, Issue 12, 2014, Pages 2023-2029

  Chen, Jian ^a,b   Zheng, Shaoxin ^a,c   Huang, Hui ^a,c   Huang, Suihua ^b   Zhou, Changqing ^a   Hou, Jingying ^a   Jiang, Jieyu ^a   Wang, Jingfeng ^a,c   Wu, Wei ^a,b   Wang, Tong ^a,c  

^a SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b THE FIFTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^c Guangdong Province Key Laboratory of Arrhythmia and Electrophysiology   (China)

Author keywords

Electrophysiology; Growth associated protein 43; Mesenchymal stem cells; Myocardial infarction; Nerve growth factor; Paracrine effects; Sympathetic remodeling; Tyrosine hydroxylase

Indexed keywords

MESSENGER RNA; NERVE GROWTH FACTOR; NEUROMODULIN; PHOSPHATE BUFFERED SALINE; TYROSINE 3 MONOOXYGENASE;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART INFARCTION; HEART NERVE SPROUTING; HEART PROARRHYTHMIA; IN VITRO STUDY; MALE; MESENCHYMAL STEM CELL; MONOCULTURE; NERVE SPROUTING; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPRAGUE DAWLEY RAT; STEM CELL CULTURE; ANIMAL; BIOSYNTHESIS; DISEASE MODEL; HEART; HEART MUSCLE CELL; INNERVATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; MYOCARDIAL INFARCTION; PATHOLOGY; PHYSIOLOGY; PROCEDURES; RANDOMIZATION;

ANIMALS; DISEASE MODELS, ANIMAL; HEART; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; NERVE GROWTH FACTORS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84898659088     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/13816128113199990451     Document Type: Article

References (41)

1. Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114: e385-e484.
2. Chen PS, Chen LS, Cao JM, et al. Sympathetic nerve sprouting, electrical remodeling and the mechanisms of sudden cardiac death. Cardiovasc Res 2001; 50: 409-416.
3. Cao JM, Chen LS, KenKnight BH, et al. Nerve sprouting and sudden cardiac death. Circ Res 2000; 86: 816-821.
4. Swissa M, Zhou S, Gonzalez-Gomez I, et al. Long-term subthreshold electrical stimulation of the left stellate ganglion and a canine model of sudden cardiac death. J Am Coll Cardiol 2004; 43: 858-864.
5. Oh YS, Jong AY, Kim DT, et al. Spatial distribution of nerve sprouting after myocardial infarction in mice. Heart Rhythm 2006; 3: 728-736.
6. Lü J, Gao X, Gu J, et al. Nerve sprouting contributes to increased severity of ventricular tachyarrhythmias by upregulating iGluRs in rats with healed myocardial necrotic injury. J Mol Neurosci 2012 Mar 2. [Epub ahead of print].
7. Zhou S, Chen LS, Miyauchi Y, et al. Mechanisms of cardiac nerve sprouting after myocardial infarction in dogs. Circ Res 2004; 95: 76-83.
8. Govoni S, Pascale A, Amadio M, et al. NGF and heart: Is there a role in heart disease? Pharmacol Res 2011; 63: 266-277.
9. Wen Z, Zheng S, Zhou C, et al. Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction. J Cell Mol Med 2011; 15: 1032-1043.
10. Wang T, Tang W, Sun S, et al. Intravenous infusion of bone marrow mesenchymal stem cells improves myocardial function in a rat model of myocardial ischemia. Crit Care Med 2007; 35: 2587-2593.
11. Wang T, Tang W, Sun S, et al. Mesenchymal stem cells improve outcomes of cardiopulmonary resuscitation in myocardial infracted rats. J Mol Cell Cardiol 2009; 46: 378-384.
12. Mills WR, Mal N, Kiedrowski MJ, et al. Stem cell therapy enhances electrical viability in myocardial infarction. J Mol Cell Cardiol 2007; 42: 304-314.
13. Ly HQ, Nattel S. Stem cells are not proarrhythmic: letting the genie out of the bottle. Circulation 2009; 119: 1824-1831.
14. Liu Y, Tse HF. The proarrhythmic risk of cell therapy for cardiovascular diseases. Expert Rev Cardiovasc Ther 2011; 9: 1593-1601.
15. Pak HN, Qayyum M, Kim DT, et al. Mesenchymal stem cell injection induces cardiac nerve sprouting and increased tenascin expression in a Swine model of myocardial infarction. J Cardiovasc Electrophysiol 2003; 14: 841-848.
16. Chang MG, Tung L, Sekar RB, et al. Proarrhythmic potential of mesenchymal stem cell transplantation revealed in an in vitro co-culture model. Circulation 2006; 113: 1832-1841.
17. Menasché, P. Stem cell therapy for heart failure: are arrhythmias a real safety concern? Circulation 2009; 119: 2735-2740.
18. Zheng SX, Weng YL, Zhou CQ, et al. Comparison of Cardiac Stem Cells and Mesenchymal Stem Cells Transplantation on the Cardiac Electrophysiology in Rats with Myocardial Infarction. Stem Cell Rev 2012 Apr 28. [Epub ahead of print]
19. Wang T, Sun S, Wan Z, et al. Effects of bone marrow mesenchymal stem cells in a rat model of myocardial infarction. Resuscitation 2012 Mar 23. [Epub ahead of print].
20. Zheng S, Zhou C, Weng Y, et al. Improvements of cardiac electrophysiological stability and ventricular fibrillation threshold in rats with myocardial infarction treated with cardiac stem cells. Crit Care med 2011; 39: 1082-1088.
21. Wang T, Tang W, Sun S,et al. Improved outcomes of cardiopulmonary resuscitation in rats with myocardial infarction treated with allogenic bone marrow mesenchymal stem cells. Crit Care Med 2009; 37: 833-839.
22. Wang T, Tang W, Sun S, et al. Intravenous infusion of bone marrow mesenchymal stem cells improves brain function after resuscitation from cardiac arrest. Crit Care Med.2008; 36: S486-S491.
23. Benzhi C, Limei Z, Ning W, et al. Bone marrow mesenchymal stem cells upregulate transient outward potassium currents in postnatal rat ventricular myocytes. J Mol Cell Cardiol 2009; 47: 41-48.
24. Li W, Ma N, Ong LL, et al. Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells 2007; 25: 2118-2127.
25. Yuan MJ, Huang CX, Tang YH, et al. A novel peptide ghrelin inhibits neural remodeling after myocardial infarction in rats. Eur J Pharmacol 2009; 618: 52-57.
26. Vassalli G, Moccetti T. Cardiac repair with allogeneic mesenchymal stem cells after myocardial infarction. Swiss Med Wkly 2011; 141: w13209.
27. Huang XP, Sun Z, Miyagi Y, et al. Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair. Circulation 2010; 122: 2419-2429.
28. Dhingra S, Huang XP, Li RK. Challenges in allogeneic mesenchymal stem cell-mediated cardiac repair. Trends Cardiovasc Med 2010; 20: 263-268.
29. Macia E, Boyden PA. Stem cell therapy is proarrhythmic. Circulation 2009; 119: 1814-1823.
30. Pinkham MI, Guild SJ, Malpas S, et al. Effects of sex and ovarian hormones on the initial renal sympathetic nerve activity response to myocardial infarction. Exp Physiol 2012 May 4. [Epub ahead of print].
31. Shi Z, Chen AD, Xu Y, et al. Long-term administration of tempol attenuates postinfarct ventricular dysfunction and sympathetic activity in rats. Pflugers Arch 2009; 458: 247-257.
32. Kim SK, Pak HN, Park JH, et al. Cardiac cell therapy with mesenchymal stem cell induces cardiac nerve sprouting, angiogenesis, and reduced connexin43-positive gap junctions, but concomitant electrical pacing increases connexin43-positive gap junctions in canine heart. Cardiol Young 2010; 20: 308-317.
33. Saygili E, Pekassa M, Saygili E, et al. Mechanical stretch of sympathetic neurons induces VEGF expression via a NGF and CNTF signaling pathway. Biochem Biophys Res Commun 2011; 410: 62-67.
34. Caporali A, Sala-Newby GB, Meloni M, et al. Identification of the prosurvival activity of nerve growth factor on cardiac myocytes. Cell Death Differ 2008; 15: 299-311.
35. Ieda M, Fukuda K. New aspects for the treatment of cardiac diseases based on the diversity of functional controls on cardiac muscles: the regulatory mechanisms of cardiac innervation and their critical roles in cardiac performance. J Pharmacol Sci 2009; 109: 348-353.
36. Rana OR, Saygili E, Meyer C, et al. Regulation of nerve growth factor in the heart: the role of the calcineurin-NFAT pathway. J Mol Cell Cardiol 2009; 46: 568-578.
37. García R, Aguiar J, Alberti E, et al. Bone marrow stromal cells produce nerve growth factor and glial cell line-derived neurotrophic factors. Biochem Biophys Res Commun 2004; 316: 753-754.
38. Cai L, Johnstone BH, Cook TG, et al. IFATS collection: Human adipose tissue-derived stem cells induce angiogenesis and nerve sprouting following myocardial infarction, in conjunction with potent preservation of cardiac function. Stem Cells 2009; 27: 230-237.
39. Wiesmann C, de Vos AM. Nerve growth factor: structure and function. Cell Mol Life Sci 2001; 58: 748-759.
40. Meloni M, Caporali A, Graiani G, et al. Nerve growth factor promotes cardiac repair following myocardial infarction. Circ Res 2010; 106: 1275-1284.
41. Zhou S, Cao JM, Swissa M, et al. Low-affinity nerve growth factor receptor p75NTR immunoreactivity in the myocardium with sympathetic hyperinnervation. J Cardiovasc Electrophysiol 2004; 15: 430-437